From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
miRNA | Level†| Cancers‡ | References |
---|---|---|---|
miR-203a-3p | Down | CRC tissues, SW480, HT29, SW620, HCT15 cell lines | Qian et al. (2019) |
 | Up | CRC tissues, HCT116, HT29, LoVo, SW1116 cell lines | Chen et al. (2018) |
 | Down | CRC tissues | Xiao et al. (2018) |
 | Down | LoVo/5-FU (5FU resistant) vs LoVo (parental sensitive) | Li et al. (2015a) |
 | Up | in serum of CRC patients | Huang et al. (2020a) |
 | Down | GC tissues and two cell lines | Wang et al. (2018a) |
 | Down | NSCLC tissues | Liang et al. (2020) |
 | Down | NSCLC tissues | Yang et al. (2020) |
 | Down | NSCLC (LUAD) tissues, TNM stage III–IV vs I–II | Wang et al. (2020a) |
 | Down | BLCA tissues and four cell lines (i.a. T24) | Na et al. (2019) |
 | Up | BRCA tissues (mainly luminal A/B) | Gomes et al. (2016) |
 | Up | HCC tissues | Huo et al. (2017) |
 | Down | PDAC four cell lines (i.a. PANC-1, SW 1990) | An and Zheng (2020) |
 | Down | OVCA tissues | Liu et al. (2019a) |